Medtronic’s Simplera Sync glucose sensor has been FDA-approved for use with its 780G insulin pumps, marking a key step in the company’s push to grow its diabetes business through smarter, more integrated insulin delivery.

Medtronic has filed for FDA clearance to make its MiniMed 780G insulin pump interoperable with glucose sensors developed by Abbott, a...

Illumina and Tempus AI have partnered to expand the use of genomic testing and precision medicine beyond oncology into broader disease areas like cardiology, neurology, and rare disorders.

Healthcare professionals reviewing protocols, reflecting the FDA's commitment to safety and collaboration in medical advancements.

A company spokesperson said Dexcom plans to resolve the agency’s concerns but stated no design changes were made to its glucose sensors.